vetmedin 0.75 mg/ml solution for injection for dogs
boehringer ingelheim animal health uk ltd - pimobendan - solution for injection - cardio vascular - dogs
vetmedin 0.75 mg/ml solution for injection for dogs
boehringer ingelheim animal health uk ltd - pimobendan - solution for injection - cardio vascular - dogs
vetmedin 5 mg flavoured chewable tablets for dogs
boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 5.0 mg/tb - cardiovascular system
vetmedin 1.25 mg flavoured chewable tablets for dogs
boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 1.25 mg/tb - cardiovascular system
vetmedin 2.5 mg flavoured chewable tablets for dogs
boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 2.5 mg/tb - cardiovascular system
vetmedin 10 mg flavoured chewable tablets for dogs
boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 10.0 mg/tb - cardiovascular system
vetmedin® chew vetmedin chew 1.25 mg chewable tablets for dogs vetmedin chew 5 mg chewable tablets for dogs vetmedin chew 10
boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - for the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid valve regurgitation). (see also section “dosage, routes and method of administration”). for the treatment of dilated cardiomyopathy in the preclinical stage (asymptomatic with an increase in left ventricular end-systolic and end-diastolic diameter) in doberman pinschers following echocardiographic diagnosis of cardiac disease (see section “special warnings” and “precautions for use in animals”). for the treatment of dogs with myxomatous mitral valve disease (mmvd) in the preclinical stage (asymptomatic with a systolic mitral murmur and evidence of increased heart size) to delay the onset of clinical symptoms of heart failure (see section “special warnings” and “special precautions for use in animals”). do not use pimobendan in hypertrophic cardiomyopathies or in diseases in which an improvement in cardiac output cannot be achieved for functional or anatomical re
vetmedin 1.25 mg flavour tablets
boehringer ingelheim ltd - pimobendan - tablets - 1.25 milligram - canine - cardiovascular
vetmedin 5.0 mg flavour tablets
boehringer ingelheim ltd - pimobendan - tablets - 5.0 milligram - canine - cardiovascular
pimobendan vetmedin 1.25 mg chewable tablets for dogs
boehringer ingelheim vetmedica gmbh - pimobendan 1.25 mg - chewable tablet - dogs - pimobendane